Alexium International Group (AJX) AI Stock Analysis

• Market Cap: AU$11.11M
• Dividend Yield: N/A
• Average Volume (3M): 135.26K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.88
• Revenue Growth: -16.41%
• EPS Growth: 59.32%
• Country: AU
• Employees: 319
• Sector: Basic Materials
• Sector Strength: 62
• Industry: Chemicals - Specialty
• EPS (TTM): >-0.01
• Shares Outstanding: 1,586,428,700
• 10 Day Avg. Volume: 118,241
• 30 Day Avg. Volume: 135,260
• PEG Ratio: 0.16
• Price to Book (P/B): 1.09
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -5.35
• Enterprise Value/Market Cap: 0.55
• Enterprise Value/Revenue: 0.21
• Enterprise Value/Gross Profit: 1.98
• Enterprise Value/Ebitda: -0.66
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 39 Underperform
• Price Target: ―

Alexium International Group Limited faces significant financial performance challenges, particularly with negative margins and cash flow issues, leading to a low overall score. The technical analysis indicates a bearish trend, further impacting the stock's outlook. Valuation metrics are unfavorable due to current losses. The absence of earnings call data and notable corporate events means these factors do not influence the overall score.

Alexium International Group Business Overview & Revenue Model

Company Description

Alexium International Group Limited manufactures and sells phase-change material (PCM) and other specialty textile solutions in the United States. It offers thermal regulation solutions, such as Alexicool, a PCM chemical finish for fabrics; Biocool, a natural and biobased PCM cooling for textile and foam bedding applications; and Eclipsys, a perpetual cooling technology that enhance the cooling experience for textile and foam bedding systems. The company also provides flame retardant solutions, such as Alexiflam, a flame-retardant treatment for cotton, linen, and other cellulosic textiles, as well as mattress applications. It serves bedding, military, and workwear markets. The company was incorporated in 1994 and is based in Greer, South Carolina.

How the Company Makes Money

Alexium International Group Limited generates revenue through the sale of its proprietary chemical formulations and treatments to manufacturers and industrial clients. The company primarily earns money from its flame retardant solutions and thermal management products that are utilized in various sectors, including textiles and advanced materials. Key revenue streams include direct sales of chemical products, licensing agreements, and strategic partnerships with manufacturers who integrate Alexium's technologies into their production processes. These partnerships often involve ongoing supply agreements, ensuring a continuous flow of revenue from repeat customers. Additionally, the company's focus on sustainable and environmentally friendly solutions helps it attract clients seeking to improve safety and compliance with regulatory standards, further contributing to its earnings.

Alexium International Group Financial Statement Overview

Summary

Alexium International Group Limited is currently facing significant financial challenges, with declining revenues and consistent profitability issues reflected in negative margins. The balance sheet indicates low leverage and a healthy equity ratio, yet the negative return on equity suggests inefficiency in using shareholder funds. The cash flow situation is worrisome, with negative free cash flow and a reliance on external financing, indicating potential liquidity risks.

Income Statement

The company exhibits a declining trend in revenue, with a revenue growth rate of -18.05% from 2023 to 2024. The gross profit margin stands at 44.77% for 2024, indicating some ability to cover cost of goods sold. However, the net profit margin is negative at -46.86%, alongside a negative EBIT margin of -41.51% and an EBITDA margin of -16.32%, highlighting significant profitability challenges.

Balance Sheet

The balance sheet reveals a relatively stable equity ratio at 63.17%, indicating a strong reliance on equity to finance assets. The debt-to-equity ratio is low at 0.29, suggesting manageable debt levels relative to equity. However, the return on equity is negative at -83.61%, reflecting poor profitability relative to shareholder investments.

Cash Flow

The cash flow statement shows negative free cash flow and operating cash flow, signaling cash management issues. The company relies heavily on financing activities for cash inflow. The operating cash flow to net income ratio is negative, further pointing to cash sustainability concerns.

Breakdown
TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
7.31M	5.89M	7.19M	8.14M	7.29M	6.10M
	Gross Profit
3.09M	2.64M	2.81M	3.32M	2.65M	2.32M
	EBIT
-989.51K	-2.45M	―	―	―	―
	EBITDA
-747.78K	-961.94K	-1.38M	-1.54M	197.76K	-3.43M
	Net Income Common Stockholders
-1.53M	-2.76M	―	―	―	―
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
3.84M	2.05M	511.78K	1.02M	2.94M	4.76M
	Total Assets
9.55M	5.23M	5.37M	6.40M	10.49M	11.72M
	Total Debt
6.78M	969.43K	4.54M	3.72M	3.38M	3.40M
	Net Debt
2.94M	-1.08M	4.02M	2.69M	446.79K	-1.36M
	Total Liabilities
9.17M	1.93M	6.35M	4.83M	6.31M	6.27M
	Stockholders Equity
382.83K	3.30M	―	1.57M	4.18M	5.45M
Cash Flow		Free Cash Flow
54.21K	-1.35M	-1.49M	-1.93M	―	―
	Operating Cash Flow
69.99K	-1.19M	-1.10M	-1.57M	―	―
	Investing Cash Flow
―	-156.22K	―	―	―	―
	Financing Cash Flow
1.73M	2.91M	992.85K	74.01K	323.38K	5.53M

Alexium International Group Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SDV	59 Neutral	AU$61.78M	30.09	4.12%	―	20.25%	―
Sector *	51 Neutral	$2.02B	-1.19	-21.37%	3.64%	2.88%	-30.57%
CXL	47 Neutral	AU$66.54M	―	-26.71%	―	15.24%	8.35%
CG1	46 Neutral	AU$18.84M	―	-73.56%	―	-6.15%	-12.45%
SPN	41 Neutral	AU$18.13M	―	-113.38%	―	―	44.09%
AJX	39 Underperform	AU$11.11M	―	-234.21%	―	-16.41%	59.32%
57N		€15.56M	―	-420.93%	―	―	―

Alexium International Group Corporate Events

Alexium International Ceases Over 1.5 Million Share Rights

Alexium International Group Limited has announced the cessation of 1,537,740 share appreciation rights as of February 17, 2025. This development may impact the company’s capital structure and could have implications for stakeholders, reflecting a potential shift in the company’s financial strategy or operational focus.

Alexium International Issues Share Appreciation Rights to Boost Employee Engagement

Alexium International Group Limited announced the issuance of 698,125 share appreciation rights as part of an employee incentive scheme. This move reflects the company’s commitment to aligning employee interests with corporate performance, potentially enhancing motivation and retention, while also indicating a strategic focus on long-term growth and value creation for stakeholders.

Alexium Issues Shares for Director Remuneration Post-Shareholder Approval

Alexium International Group Limited has issued 9,917,255 ordinary shares as director remuneration for the second half of 2024, following shareholder approval at the 2024 Annual General Meeting. This issuance was conducted without disclosure under the Corporations Act 2001, and the company confirms compliance with relevant legislative provisions, ensuring no undisclosed information affects investor assessments of the company’s financial position or share rights.

Alexium International Releases Half-Year Financial Report

Alexium International Group Limited has released its half-year financial report for the six months ending December 31, 2024. The report, presented in US dollars, includes various financial statements such as the consolidated statement of profit or loss, financial position, changes in equity, and cash flows. The announcement provides insights into the company’s financial performance and operational status, which are critical for stakeholders to assess the company’s market position and future prospects.